A Two-Way Interaction Study Between RO5190591/RTV and Ketoconazole in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 12 Sep 2016
At a glance
- Drugs Danoprevir (Primary) ; Ketoconazole; Ritonavir
- Indications Hepatitis C; HIV infections
- Focus Pharmacokinetics
- Sponsors Roche
- 18 Apr 2012 Planned End Date changed to 1 Nov 2010, according to ClinicalTrials.gov record.
- 18 Apr 2012 Status changed from not yet recruiting to completed, according to ClinicalTrials.gov record.
- 23 Jul 2010 New trial record